Search

Wong, Kimberly, and Larry Benowitz. 2022. “Retinal Ganglion Cell Survival and Axon Regeneration After Optic Nerve Injury: Role of Inflammation and Other Factors”. Int J Mol Sci 23 (17).

Baldwin, Grace, Jared Sokol, Cassie Ludwig, and John Miller. 2022. “A Comparative Study of Traditional Scleral Buckling to a New Technique: Guarded Light Pipe With Heads-Up Three-Dimensional Visualization”. Clin Ophthalmol 16: 3079-88.

Oke, Isdin, Gena Heidary, Iason Mantagos, Ankoor Shah, and David Hunter. 2022. “A Decline in the Strabismus Surgical Experience of Ophthalmology Residents in the United States from 2010 to 2019”. J AAPOS.

Ho, Tiffany, Robi Maamari, Andrea Kossler, Connie Sears, Suzanne Freitag, Edith Reshef, Roman Shinder, et al. 2022. “Outcomes of Patients With Thyroid Eye Disease Partially Treated With Teprotumumab”. Ophthalmic Plast Reconstr Surg.

Hoyek, Sandra, Bryan Peacker, Luis Acaba-Berrocal, Hasenin Al-Khersan, Yan Zhao, Mary Elizabeth Hartnett, Audina Berrocal, and Nimesh Patel. 2022. “The Male to Female Ratio in Treatment-Warranted Retinopathy of Prematurity: A Systematic Review and Meta-Analysis”. JAMA Ophthalmol 140 (11): 1110-20.

Noro, Takahiko, Sahil Shah, Yuqin Yin, Riki Kawaguchi, Satoshi Yokota, Kun-Che Chang, Ankush Madaan, et al. 2022. “Elk-1 Regulates Retinal Ganglion Cell Axon Regeneration After Injury”. Sci Rep 12 (1): 17446.

Freedman, Sharon, Amra Hercinovic, David Wallace, Raymond Kraker, Zhuokai Li, Amit Bhatt, Charline Boente, et al. 2022. “Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes”. Ophthalmology 129 (10): 1120-28.

Oke, Isdin, Nathan Hall, Joan Miller, Alice Lorch, and David Hunter. 2022. “Reply”. Ophthalmology.

Levy, Michael, Bart Chwalisz, Benjamin Kozak, Michael Yoon, Helen Shih, and Anna Stagner. 2022. “Case 36-2022: A 30-Year-Old Woman With Decreased Vision and Headache”. N Engl J Med 387 (21): 1980-89.

Peng, De-Wei, Chun-Lin Lan, Ling-Qin Dong, Meng-Xi Jiang, Huan Xiao, Robert D’Amato, and Zai-Long Chi. 2022. “Anti-Angiogenic Properties of MicroRNA-29a in Preclinical Ocular Models”. Proc Natl Acad Sci U S A 119 (45): e2204795119.